Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials
AMPLIFY Phase III trial results demonstrated statistically significant and clinically meaningful improvement in progression-free survival for Calquence combinations
Emcure has launched an awareness campaign to help spread the word about male anemia
Quinidine Sulphate helps manage rare irregular heartbeat conditions
The study observed 2,648 girls, of which 2,300 completed the standard 45-day programme
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
Dyslipidemia is a critical risk factor for cardiovascular diseases
Sun Pharma's Dadra facility receives OAI status from US FDA
Decision on EU marketing authorisation expected for momelotinib by early 2024
Subscribe To Our Newsletter & Stay Updated
